An observational study in Asthma, sponsored by Capital Institute of Pediatrics, China. Completed at 1 site in China. Open to participants aged 4 Years to 12 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-09-28.
Sponsored by Capital Institute of Pediatrics, China · Observational
Objectives:
Background and rationale:
According to the guidelines spirometry, including baseline forced expiratory volume in 1 second (FEV1) and the bronchodilator response (BDR) to short acting beta agonists (SABA), should be used in children as objective measures to establish the diagnosis and severity of bronchial asthma. Baseline FEV1 is usually in the normal range (greater than 80% predicted) in children, regardless of asthma severity, so several other objective measures have been suggested for diagnosis in children, including the response to a bronchodilator, which reflects airway reversibility.
The current definition for a positive BDR is >12% reversibility. In the study carried out by Galant et al among 51 non-asthmatic children and 346 controller naïve asthmatic children between 4-17 years, the BDR value could achieve 12% in only 30.6% asthmatic children, across all severity. Also, in a study among 142 children between 5-10 years in UK, 9% increase in FEV1 after bronchodilator use was suggested as the cutoff point with good sensitivity and specificity.
Difference between the proposed study to be carried out in our hospital and the one in Anhui Province is that we will tentatively calculate a BDR cutoff point by using receiver operating characteristic (ROC curve). And the cutoff point can be used as a reference indicator in asthma diagnosis and long-term management.
The current BDR cutoff point of 12% that is not ideal for children can also be reflected in the clinical management. It has been shown that a persistent BDR value, even less than 12%, in asthmatic children suggests poor clinical outcome. In a 4 years study among 1041 asthmatic children in America carried out by Sharma et al, it showed that compared with individuals who had a BDR of 12% and 200ml, individuals who had a BDR of 10% had similar poor clinical outcomes (e.g. more hospital visits, more prednisone bursts, increased nocturnal awakenings, and missing more days of school). Same results were also obtained in Galant et al study among 679 asthmatic children among 5-18 years.
This is a prospective observational non-interventional clinical study.
300 non-asthmatic and 300 asthmatic children will be recruited.
Non-asthmatic group: healthy children from 4-12 years will be recruited from the Capital Institute of Pediatrics nearby schools
Inclusion criteria:
Exclusion criteria:
Asthmatic group: 4-12 years old asthmatic children will be recruited from the asthma clinic of the Capital Institute of Pediatrics
Inclusion criteria:
Exclusion criteria:
Standardized pulmonary function tests will be conducted.
Contents of tests:
Pre and post flow volume: forced volume vital capacity (FVC), FEV0.5, FEV1, FEV1/FVC ratio, PEF, forced expiratory flow 25 (FEF25), FEF50, FEF75, FEF25-75, forced expiratory time (FET), back-extrapolated volume (VBE), VBE/FVC.
The BDR is based on pulmonary function measurements before and after administration of 2.5 mg albuterol by nebulizer. BDR is calculated as [(postbronchodilator FEV1- baseline FEV1)/baseline FEV1] x 100%.
Study Procedures:
Calibration: Before calibration, the room temperature, pressure, humidity should be tested and recorded and all of the parameter should be reconciled to BTPS condition.
Using 2 liters scalar to calibrate flow. Every day do the even flow calibration. Every week do the flow linear calibration, include high, media and low flow these three different flow calibration. The variety should be less than 3%.
The record of calibration should be printed, and the technician should be signed on it and save it.
3,921 studies on the registry are indexed under Asthma; 507 are open to participants now.
This study's enrollment of 587 is above the median of 150 across 970 observational studies indexed under Asthma.
Browse Asthma studies →Capital Institute of Pediatrics, China is the lead sponsor of 4 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
300 asthmatic children and 300 non-asthmatic children will be recruited
-Non-asthmatic group: healthy children from 4-12 years will be recruited from the Capital Institute of Pediatrics nearby schools
Inclusion criteria:
Exclusion criteria:
The children can not finish the test that met American Thoracic Society criteria for preschool children in a maximum of 6 attempts and are unable to successfully complete post-bronchodilator (BD) spirometry
Inclusion criteria:
Exclusion criteria:
children diagnosed by a specialist as asthmatic patients
children who are healthy and who do not have respiratory syndrom
Bronchodilator Response in Asthmatic Children
1. To observe bronchodilator response(BDR) distribution curve for Chinese non-asthmatic children from 4-12 years, BDR calculated as: (FEV 1 L post-bronchodilator - FEV 1 L pre-bronchodilator)/FEV 1 L pre-bronchodilator × 100%. 2. To observe BDR distribution curve for Chinese controller-naïve asthmatic children from 4-12 years 3. To compare BDR values between non-asthmatic group and controller-naïve asthmatic group, and analyze appropriate cut-off point value
Time frame: 3 years
| Milestone | Asthmatic Children | Non-asthmatic Children |
|---|---|---|
| Started | 286 | 301 |
| Completed | 286 | 301 |
| Not completed | 0 | 0 |
1. To observe bronchodilator response(BDR) distribution curve for Chinese non-asthmatic children from 4-12 years, BDR calculated as: (FEV 1 L post-bronchodilator - FEV 1 L pre-bronchodilator)/FEV 1 L pre-bronchodilator × 100%. 2. To observe BDR distribution curve for Chinese controller-naïve asthmatic children from 4-12 years 3. To compare BDR values between non-asthmatic group and controller-naïve asthmatic group, and analyze appropriate cut-off point value
| percentage of BDR | Asthmatic Children | Non-asthmatic Children |
|---|---|---|
| Bronchodilator Response in Asthmatic Children | 9.45 ± 9.15 | 3.30 ± 3.85 |
Collected over 30 minutes. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Asthmatic Children | 0/286 (0%) | 0/286 (0%) | 0/286 (0%) |
| Non-asthmatic Children | 0/301 (0%) | 0/301 (0%) | 0/301 (0%) |
| Age, Continuous(years) | Asthmatic Children | Non-asthmatic Children | Total |
|---|---|---|---|
| Mean | 7.22 ± 2.44 | 7.56 ± 2.41 | 7.41 ± 2.43 |
| Sex: Female, Male(Participants) | Asthmatic Children | Non-asthmatic Children | Total |
|---|---|---|---|
| Female | 92 | 141 | 233 |
| Male | 194 | 160 | 354 |
This study is completed, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Capital Institute of Pediatrics, China